Nod to Sputnik V

Date:

spot_imgspot_img

New Delhi, April 12: India’s drug regulator has granted permission for the restricted emergency use of Russian COVID-19 vaccine ‘Sputnik V’ with certain conditions, paving the way for a third vaccine to be available in the country, sources said on Monday.
The DCGI had in January given the emergency use authorisation for two COVID-19 vaccines — Covaxin of Bharat Biotech and Covishield of Oxford-AstraZeneca manufactured by Serum Institute of India in Pune.
According to sources, around 10 crore doses of the Sputnik V vaccine is likely to be imported for emergency use in the country in the next six to seven months. (PTI)

spot_imgspot_img

Related articles

This Horrific Murder Demands Soul Searching

Editor I write to express my horror at the death of four year old Insaphira Lyngdoh Mawnai, of Nongrah,...

Cabinet Rejig Defies Logic

The MDA-2 Government had only one lady minister and she was dropped thereby turning the present cabinet into...

Are we brave enough to let public office become a trust- not a dowry?

By Napoleon S Mawphniang Nepotism—our insidious "uncle culture"—has entangled itself within Meghalaya's executive, legislative, and recruitment channels, promising merit...

Before and After AI: Are we losing the Art of Thinking?

By Argh Jain Open AI has released its GPT 5.0, Perplexity AI has put the offer to buy...